Pathway Rx
Pathway Research (Pathway Rx) is a research company dedicated to studying the effectiveness of cannabis compounds and developing custom cannabis therapies aimed at treating specific ailments and diseases. Pathway Rx Founder and CEO, Dr. Igor Kovalchuk is an award-winning expert in genetics and molecular biology and is one of the first researchers to be granted a Health Canada cannabis research license. Pathway Rx operates in partnership with the University of Lethbridge and other companies including Swysh Inc, an oral health product developer, InPlanta Biotechnology, a licensed cannabis nursery that generated over hybrids, and Sundial Growers (“Nasdaq: SNDL”), an Alberta-based licensed cannabis producer.
7-day free trial · no credit card
Verified contacts
2
available on Kipplo
LinkedIn employees
6
1 to 10 range
Open roles
—
no listings
Distinct roles
2
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 2 verified contacts at Pathway Rx
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
2 contacts with verified email or phone · masked until revealed.
No verified contacts on record for this company yet.
Top roles at Pathway Rx
2 distinct titles indexed · top 2 shown.
- 1dotnet intern
- 1sap materials management consultant
Sign up to unlock all 2 contacts at Pathway Rx
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 2 verified contacts at Pathway Rx
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.